Cardiopulmonary Stress Testing Systems Market - Regional Analysis
North American Market Insights
North America industry is estimated to dominate majority revenue share of 36% by 2035. The growth can be attributed to the prevalence of cardiovascular and pulmonary disorders such as arrhythmia, heart failures, ischemic heart disease, dyspnea, and heart valve imbalance in the United States, generating higher demand for CPST systems. For example, the prevalence of obesity was 39.7% in 2021, which is very high, according to an update from the CDC published in May 2022.
Cardiopulmonary diseases are also caused by obesity as a result, driving the market's growth. The region’s high share of total revenue is due to the rise in lifestyle diseases, as well as increased awareness amongst medical professionals on the benefits of CCPT and access to modern healthcare infrastructure across the region.
European Market Insights
The cardiopulmonary stress testing systems market in the Europe region is set to grow significantly during the time period 2026-2035. The growth of the German market in the region is driven by increasing demand for cardiovascular disease monitoring and diagnostic devices.
In addition, an increase in elderly patients, and increasing awareness of stress tests boost the market growth of cardiopulmonary stress testing systems. Moreover, market revenue in Germany is driven by the high adoption and penetration of advanced testing systems in public health centers and institutions that assist nurses and doctors in real-time monitoring of patients' health.
